503 related articles for article (PubMed ID: 99030)
1. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
2. Vasodilators in myocardial infarction: rationale and current status.
Amsterdam EA; Awan NA; DeMaria AN; Mason DT
Drugs; 1978 Dec; 16(6):506-21. PubMed ID: 365511
[TBL] [Abstract][Full Text] [Related]
3. Afterload reduction in the treatment of cardiac failure.
Mason DT
Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
Franciosa JA; Cohn JN
Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
[TBL] [Abstract][Full Text] [Related]
6. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
Malacco E; Limonta A; Milanesi A; Micossi P
Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
[TBL] [Abstract][Full Text] [Related]
7. [Differential therapy of heart insufficiency].
Gilfrich HJ
Fortschr Med; 1982 Nov; 100(43):1993-6. PubMed ID: 7152435
[TBL] [Abstract][Full Text] [Related]
8. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
10. The use of vasodilator agents in the treatment of heart failure.
Lloyd EA
S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of congestive heart failure by using vasodilators. I. Physiological basis. Different vasodilators (author's transl)].
Solignac A
Nouv Presse Med; 1978 Mar; 7(12):1013-20. PubMed ID: 96422
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
Zilcher H
Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
[TBL] [Abstract][Full Text] [Related]
13. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Mehta J; Iacona M; Pepine CJ; Conti CR
Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
[TBL] [Abstract][Full Text] [Related]
14. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
[TBL] [Abstract][Full Text] [Related]
15. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Packer M; Medina N; Yushak M
Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
Klein W; Brandt D; Harpf H; Goebel R
Wien Med Wochenschr; 1979 Nov; 129(21):625-30. PubMed ID: 120080
[TBL] [Abstract][Full Text] [Related]
17. Effects of arteriolar vasodilators on hepatic venous compliance and cardiac output in anesthetized cats.
Greenway CV; Innes IR
J Cardiovasc Pharmacol; 1981; 3(6):1321-31. PubMed ID: 6173533
[TBL] [Abstract][Full Text] [Related]
18. Combination vasodilator therapy for severe chronic congestive heart failure.
Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Chatterjee K; Parmley WW
J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
